Q3 2026 Electromed Inc Earnings Call Transcript

May 12, 2026 / 09:00 PM GMT

Release Date Price: $27.2 (+4.90%)

Transcript 10-Q8-K

Key Points

Positve

Electromed Inc (ELMD) achieved its 14th consecutive quarter of year-over-year revenue and profit growth, with Q3 revenue reaching $18.6 million, an 18.4% increase from the previous year.
The company's operating income increased by 76% to $3.8 million, showcasing strong financial performance.
Electromed Inc (ELMD) maintained a strong cash position of $17 million and has no debt, indicating financial stability.
The company successfully launched the 'Triple Down on Bronchiectasis' campaign, which has generated over 2 million impressions and increased awareness among clinicians.
Electromed Inc (ELMD) has expanded its sales force to 62 representatives, enhancing market coverage and driving revenue growth.

Negative

Despite the growth, Electromed Inc (ELMD) experienced a 40.7% decline in other revenue, indicating potential challenges in certain segments.
The company faced increased SG&A expenses, rising by 7.2% due to higher salaries and compensation costs.
There is a significant gap in the prescription of HFCWO therapy, with 58% of qualifying patients not receiving it, highlighting a missed opportunity.
The ramp-up period for new sales representatives is four to six months, which could delay immediate productivity and revenue contributions.
Electromed Inc (ELMD) slowed its stock repurchase activity in Q3 due to macro market dynamics, which may affect shareholder returns.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ELMD.A - Electromed Inc
Q3 2026 Electromed Inc Earnings Call
May 12, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings, and welcome to the ElectroMed Fiscal Q3 2026 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone requires operator assistance during the conference, please press *0 on your telephone keypad. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mike Kavanaugh, Investor.

You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon, and thank you for joining the ElectroMed earnings call. Earlier

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.